Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (161-170 of 721) with videos related to

Pageof 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2022
Is <sup>18</sup>F-FDG PET Needed to Assess <sup>177</sup>Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center AnalysisRobert Seifert, Tugce Telli, Boris Hadaschik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2019
Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of PrometheusLisa Bodei, Ken Herrmann, Richard P Baum, et al.
Trials|February 6, 2019
Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma: study protocol for a multicentric randomized controlled trialIngo Stoffels, Ken Herrmann, Jan Rekowski, et al.
Seminars in Musculoskeletal Radiology|April 10, 2014
PET tracers in musculoskeletal disease beyond FDGHinrich A Wieder, Kelsey L Pomykala, Matthias R Benz, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 1, 2008
The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategiesKatja Ott, Florian Lordick, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approachesAndreas K Buck, Ken Herrmann, Tom Stargardt, et al.
Clinical Nuclear Medicine|February 8, 2023
Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors With the Clinical Application of FAPI Imaging?Roberto C Delgado Bolton, Adriana K Calapaquí Terán, Ken Herrmann, et al.
Radiologie (Heidelberg, Germany)|September 16, 2022
[Oncological theranostics in nuclear medicine]Christina Laschinsky, Ken Herrmann, Wolfgang Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2020
<sup>18</sup>F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosisMaria Papathanasiou, Alexander Carpinteiro, Tim Hagenacker, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 16, 2025
Theranostics in surgical oncologyS Stättner, Kjetil Soreide, Julie Hallet, et al.
Pageof 73

Showing results (161-170 of 721) with videos related to

Sort By:
Pageof 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2022
Is <sup>18</sup>F-FDG PET Needed to Assess <sup>177</sup>Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center AnalysisRobert Seifert, Tugce Telli, Boris Hadaschik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2019
Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of PrometheusLisa Bodei, Ken Herrmann, Richard P Baum, et al.
Trials|February 6, 2019
Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma: study protocol for a multicentric randomized controlled trialIngo Stoffels, Ken Herrmann, Jan Rekowski, et al.
Seminars in Musculoskeletal Radiology|April 10, 2014
PET tracers in musculoskeletal disease beyond FDGHinrich A Wieder, Kelsey L Pomykala, Matthias R Benz, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 1, 2008
The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategiesKatja Ott, Florian Lordick, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approachesAndreas K Buck, Ken Herrmann, Tom Stargardt, et al.
Clinical Nuclear Medicine|February 8, 2023
Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors With the Clinical Application of FAPI Imaging?Roberto C Delgado Bolton, Adriana K Calapaquí Terán, Ken Herrmann, et al.
Radiologie (Heidelberg, Germany)|September 16, 2022
[Oncological theranostics in nuclear medicine]Christina Laschinsky, Ken Herrmann, Wolfgang Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2020
<sup>18</sup>F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosisMaria Papathanasiou, Alexander Carpinteiro, Tim Hagenacker, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 16, 2025
Theranostics in surgical oncologyS Stättner, Kjetil Soreide, Julie Hallet, et al.
Pageof 73